Serum 14-3-3β protein: a new biomarker in asthmatic patients with acute exacerbation in an observational study
Open Access
- 9 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 17 (1), 1-8
- https://doi.org/10.1186/s13223-021-00608-4
Abstract
The determination of systemic inflammatory markers is one of the important directions to study the pathogenesis of asthma and improve the diagnosis of asthma. Current studies have found that the 14-3-3 protein family subtypes interact with target proteins to participate in the pathogenesis of a variety of immune inflammatory diseases. However, studies on serum tyrosine3-monooxygenase/tryptophan5-monooxygenase activation protein β (14-3-3β) in asthma are scarce. This study aimed to assess the clinical significance of 14-3-3β in asthmatic patients. We recruited 54 asthmatic patients with acute exacerbation and 50 asthmatic patients with chronic persistent. The normal control group included 54 healthy individuals. Clinical characteristics, clinical indicators [fractional expiratory nitric oxide (FeNO), eosinophil count, forced vital capacity (FVC), percent of predicted FVC (FVC% predicted), forced expiratory volume in one second (FEV1), percent of predicted FEV1 (FEV1% predicted), the ratio of forced expiratory volume in one second to forced vital capacity (FEV1/FVC) and serum 14-3-3β levels were measured to compare among each group. Spearman’s rank correlation coefficient was used to evaluate the correlation between 14-3-3β and clinical indicators. Finally, Receiver-operating characteristic (ROC) curves analysis was used to determine the sensitivity and specificity of 14-3-3β. Our results showed that median (interquartile range) of serum 14-3-3β concentration (ng/mL) in acute exacerbation group of asthma (41.18 [33.06–51.76]) was much higher than that in normal control group (24.99 [17.43–29.91]; P < 0.001) and chronic persistent group of asthma (25.88 [21.03–34.55]; P < 0.001). Spearman’s correlation coefficient shows that the serum 14-3-3β level was positively correlated with FeNO (r = − 0.292, P = 0.032) and peripheral blood eosinophil count (r = 0.328, P = 0.016), and was negatively related to FEV1/FVC (r = − 0.293, P = 0.031) in the acute exacerbation group of asthma. At the same time, the serum 14-3-3β level was also negatively associated with FEV1 (r = − 0.297, P = 0.036) in the chronic persistent group of asthma. ROC curve analysis comparing acute exacerbation group of asthma with normal control group demonstrated a significant (P < 0.001) AUC of 0.90 (95% CI 0.85–0.96). The serum 14-3-3β protein may become a potential biomarker in asthmatic patients with acute exacerbation.Keywords
Funding Information
- National Natural Science Foundation of China (81760008, 81460005)
This publication has 30 references indexed in Scilit:
- Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritisRheumatology, 2017
- The role of the 14-3-3 protein family in health, disease, and drug developmentDrug Discovery Today, 2016
- Molecular Dynamics Simulations and Structural Analysis of Giardia duodenalis 14-3-3 Protein–Protein InteractionsJournal of Chemical Information and Modeling, 2015
- Blood eosinophil count and prospective annual asthma disease burden: a UK cohort studyThe Lancet Respiratory Medicine, 2015
- Biomarker-based asthma phenotypes of corticosteroid responseJournal of Allergy and Clinical Immunology, 2014
- External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthmaThorax, 2014
- Serum 14-3-3η is a Novel Marker that Complements Current Serological Measurements to Enhance Detection of Patients with Rheumatoid ArthritisThe Journal of Rheumatology, 2014
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- 14-3-3 proteins in the nervous systemNature Reviews Neuroscience, 2003
- Direct Interaction between Protein Kinase Cθ (PKCθ) and 14-3-3τ in T Cells: 14-3-3 Overexpression Results in Inhibition of PKCθ Translocation and Function†Molecular and Cellular Biology, 1996